ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.774,71
0,43%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08595
0,11%
Bitcoin
69.577,69
1,56%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Lucid Diagnostics Inc (LUCD)

  7. Lucid Diagnostics Inc (LUCD) News

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LUCD
DatumZeitQuelleÜberschriftSymbolFirma
24/05/202423h26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:LUCDLucid Diagnostics Inc
24/05/202422h32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LUCDLucid Diagnostics Inc
24/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
14/05/202412h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
14/05/202402h43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/05/202414h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
13/05/202414h00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
10/05/202403h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
10/05/202403h57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
09/05/202413h49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:LUCDLucid Diagnostics Inc
08/05/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
08/05/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
07/05/202413h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
07/05/202413h39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:LUCDLucid Diagnostics Inc
02/05/202414h35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
02/05/202413h49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
29/04/202414h47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:LUCDLucid Diagnostics Inc
08/04/202414h30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LUCDLucid Diagnostics Inc
27/03/202400h32PR Newswire (US)PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
25/03/202422h30PR Newswire (US)Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
21/03/202414h30PR Newswire (US)Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:LUCDLucid Diagnostics Inc
20/03/202413h30PR Newswire (US)Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceNASDAQ:LUCDLucid Diagnostics Inc
12/03/202413h30PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024NASDAQ:LUCDLucid Diagnostics Inc
23/02/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
16/02/202423h00PR Newswire (US)Lucid Diagnostics Provides Update Regarding World Trade Center Health ProgramNASDAQ:LUCDLucid Diagnostics Inc
15/02/202413h45PR Newswire (US)Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyNASDAQ:LUCDLucid Diagnostics Inc
08/02/202413h45PR Newswire (US)Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsNASDAQ:LUCDLucid Diagnostics Inc
06/02/202423h24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
06/02/202423h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
30/01/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:LUCD

Kürzlich von Ihnen besucht

COIN
MMCOBTC
USOTC
MECVF
MDF Commerce (PK)
USOTC
CCNB
Coastal Carolina Bancsha... (QX)
LSE
79WE
Oq Saoc 28a
USOTC
SPQDF
Specialty Liquid (CE)
EU
INCG1
Casam Etf CG1 Inav
AMEX
EZM
WisdomTree US MidCap
HITB
GNSUSDT
Gains Network
BOV
AVLL3R
Alphaville ON
USOTC
CVSY
Convergence Systems (GM)
EU
SNCF
SNCF 2.455% 22jun2047
BOV
R1IN34M
Realty Incomdrn
EU
HIUS
HSBC ETFs
AMEX
SDOW
ProShares UltraPro Short...
AMEX
MRT
Marti Technologies
OKEX
XEMUSDT
NEM
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten